Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Independence Blue Cross | Chiropractic ServicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA10-004 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Chimeric Antigen Receptor T-cell (CAR-T) Therapy: Carvykti and AbecmaPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-190 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Chimeric Antigen Receptor (CART) Therapy: Yescarta Tecartus, Breyanzi, Kymriah and AucatzylPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-093 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Chemical PeelsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-103 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Cetuximab (Erbitux)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-031 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Cervical Traction Devices for In-home UsePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-009 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Cerliponase alfa (Brineura)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-089 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Cemiplimab-rwlc (Libtayo)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-124 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Catheter Ablation of Cardiac ArrhythmiasPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-060 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Cataract SurgeryPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-054 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Cast and Splint Applications and Associated SuppliesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-012 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Carfilzomib (Kyprolis)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-062 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Care Management and Care Planning ServicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-006 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Cardiac Rehabilitation (CR) and Intensive Cardiac Rehabilitation (ICR) ProgramsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA10-002 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Cardiac Contractility ModulationPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-038 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Capsule EndoscopyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-022 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Canes and CrutchesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-052 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Canakinumab (Ilaris)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-101 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Burosumab-twza (Crysvita)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-099 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Bundled Procedure CodesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-026AA-49676FE50F | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Bronchial ValvesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-020 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Brentuximab Vedotin (Adcetris)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-068 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Botulinum Toxin AgentsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-017 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing AidsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-049 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Blinatumomab (Blincyto)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-058 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Bioimpedance for the Detection of LymphedemaPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-052 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Biofeedback TherapyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-010 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Billing for Professional Office-Based Services Performed in an Outpatient Office-Based Setting Located within a Facility or on a Facility CampusPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-037 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Bevacizumab (Avastin) and Related Biosimilars For Oncologic UsePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-072 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Belimumab (Benlysta) for Intravenous UsePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-057 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Belantamab mafodotin-blmf (Blenrep)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-192 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Balloon Catheter Dilation of Sinus Ostia for Treatment of Chronic Rhinosinusitis or Recurrent Acute RhinosinusitisPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-100 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Axatilimab-csfr (Niktimvo) for Intravenous UsePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-180 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Avelumab (Bavencio)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-122 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Autonomic Nervous System TestingPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-027 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Automatic External Cardioverter Defibrillators (Wearable and Nonwearable)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-005 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Auricular ProsthesesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-068 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Atezolizumab (Tecentriq) and Atezolizumab with Hyaluronidase-tqjs (Tecentriq Hybreza)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-127 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Asparaginase Erwinia Chrysanthemi (recombinant)-rywn (Rylaze)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-085 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Aqueous Shunts, Minimally Invasive Glaucoma Surgeries (including Microstents), Viscocanalostomy, and Canaloplasty for the Treatment of GlaucomaPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-105 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Application and Removal of TattoosPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-072 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Apos biomechanical shoe systemPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-070 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Apheresis TherapyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA06-001 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Ankle-Foot/Knee-Ankle-Foot OrthosisPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-010 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Anifrolumab-fnia (Saphnelo)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-140 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Anesthesia Services for Epidural, Paravertebral Facet and Sacroiliac Joint Injections for Spinal Joint ManagementPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA01-008 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Amivantamab-vmjw (Rybrevant) and Amivantamab and hyaluronidase-lpuj (Rybrevant Faspro)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-148 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Ambulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) MonitoringPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-026 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Ambulatory Blood Pressure Monitoring (ABPM) and Home Blood Pressure Monitoring (HBPM) DevicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-005 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Alpha-1 Antitrypsin Therapy (e.g., Prolastin-C, Aralast NP, Glassia, Zemaira)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-050 | New policy |
|---|